Medicament dosage for inhaler

• US 20100012118A1
• Filed: 07/09/2009
• Published: 01/21/2010
• Est. Priority Date: 07/19/2008
• Status: Abandoned Application

• Current Assignee: Markus Storz
• Original Assignee: Markus Storz
• Inventors: Storz, Markus
• Application Number:
  US12/459,899
• Publication Number:
  US 20100012118A1
• Time in Patent Office: Days
• US Class Current: 128/203.150
• CPC Class Codes: A61M 11/04 operated by the vapour pressure of the liquid to be sprayed or atomised air-humidification, e.g. "room humidifiers" F24F6/00
• CPC Class Codes: A61M 11/041 using heaters
• CPC Class Codes: A61M 15/00 Inhalators drug delivery in endotracheal tubes A61M16/04
• CPC Class Codes: A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

The manual filling of vaporizable substances into the filling chamber of an inhaler by the user is suitable, in particular, for the requirements of a medical application only in limited circumstances. As a rule, there is the risk of an incorrect dosage. Moreover, many patients are not at all capable of carrying out such a difficult task owing to their motor skills ailments or other conditions that render them disabled. Medical application therefore requires an economical form that has already been pre-dosed with the desired substance (medicament) by the pharmacist or the pharmaceutical company and that is a standardized single-use component. A dosage pad that has already been pre-dosed by the manufacturer ensures that the proper amount of medication is used. In particular, a dosage pad containing a medicament that is vaporizable by heat in an inhaler and that is effectual upon inhalation avoids the problems associated attempting to fill an inhaler manually with the correct dosage.

Claims

1. A dosage of a medicament that is vaporizable by means of heat action and that is effectual upon inhalation, dosage for an application and manageably arranged as a component for use in an inhaler.

2. The dosage of claim 1 characterized in that the medicament has herbal cannabis, cannabis extract, cannabinoid or an opioid.

3. The dosage of claim 2 wherein the medicament is herbal cannabis.

4. The dosage of claim 3 wherein the amount of herbal cannabis in the dosage ranges from 10 to 1000 mg.

5. The dosage of claim 2 wherein the medicament is cannabis extract or cannabinoid.

6. The dosage of claim 5 wherein the amount of cannabis extract or cannabinoid in the dosage ranges from 1 to 100 mg.

7. The dosage of claim 1 characterized in that the vaporizable substances are located in a layer of material that is permeable to air and vapor.

8. The dosage of claim 1 characterized in that the vaporizable substances are located between two protective layers of material that is permeable to air and vapor and the circumferential edges of which are connected to each other.

9. The dosage of claim 1 characterized in that an additional layer, which is located between two protective layers of material that is permeable to air and vapor, serves to receive liquid substances or solutions.

10. The dosage of claim 1 characterized in that the dosage is packaged in a protective environment.

11. The use of a dosage as specified in claim 1 in an inhaler.

12. A method of treating pain in a human comprising the steps of:

providing a dosage pad containing a therapeutically effective amount of herbal cannabis;

inserting the dosage pad into the filling chamber of an inhaler;

vaporizing aromatics and active ingredients containing cannabinoid from the herbal cannabis;

introducing the aromatics and active ingredients into a container; and

inhaling the aromatics and active ingredients from the container.

13. The method of claim 12 characterized in that the herbal cannabis is located in a layer of material that is permeable to air and vapor.

14. The method of claim 12 characterized in that the vaporizable substances are located between two protective layers of material that is permeable to air and vapor and the circumferential edges of which are connected to each other.

15. The method of claim 12 wherein the amount of herbal cannabis in the dosage pad ranges from 10 to 1000 mg.